Glomerulosclerosis, Focal Segmental
Showing 1 - 25 of 1,573
Genetic Markers for Focal Segmental Glomerulosclerosis
Completed
- Focal Segmental Glomerulosclerosis
- HIV-Associated Focal Segmental Glomerulosclerosis
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Focal Segmental Glomerulosclerosis Trial (Metformin + Standard of Care, Placebo + Standard of Care)
Not yet recruiting
- Focal Segmental Glomerulosclerosis
- Metformin + Standard of Care
- Placebo + Standard of Care
- (no location specified)
Oct 13, 2023
Focal Segmental Glomerulosclerosis and Minimal Change Disease
Not yet recruiting
- Focal Segmental Glomerulosclerosis
- +3 more
- Biospecimen collection
- Data collection
-
Ann Arbor, MichiganUniversity of Michigan
Dec 6, 2022
LDL-Apheresis for FSGS CardioRenal Outcomes
Enrolling by invitation
- Focal Segmental Glomerulosclerosis
- No intervention
-
Cincinnati, Ohio
- +1 more
Jan 25, 2023
Focal Segmental Glomerulosclerosis (FSGS) Trial (VX-147)
Not yet recruiting
- Focal Segmental Glomerulosclerosis (FSGS)
- (no location specified)
Jul 13, 2023
Focal Segmental Glomerulosclerosis (FSGS) Trial (IXP)
Not yet recruiting
- Focal Segmental Glomerulosclerosis (FSGS)
- (no location specified)
May 9, 2023
IgA Nephropathy, Focal Segmental Glomerulosclerosis Trial in Nanjing (HS-10390 tablet, Placebo tablet)
Recruiting
- IgA Nephropathy
- Focal Segmental Glomerulosclerosis
- HS-10390 tablet
- Placebo tablet
-
Nanjing, Jiangsu, ChinaZhongda Hospital, Affiliated to Southeast University
Jul 12, 2023
Minimal Change Disease, Focal Segmental Glomerulosclerosis Trial in United States (VB119)
Recruiting
- Minimal Change Disease
- Focal Segmental Glomerulosclerosis
-
Los Angeles, California
- +7 more
Jul 19, 2022
Focal Segmental Glomerulosclerosis Trial in Australia (Propagermanium, Placebo)
Completed
- Focal Segmental Glomerulosclerosis
- Propagermanium
- Placebo
-
Gosford, New South Wales, Australia
- +10 more
Jul 28, 2022
Humanistic Burden of Focal Segmental Glomerulosclerosis and IgAN
Recruiting
- Focal Segmental Glomerulosclerosis
- Immunoglobulin A Nephropathy
-
Belmar, New Jersey
- +2 more
Apr 12, 2022
Glomerulosclerosis, Focal Segmental, Minimal Change Disease, Idiopathic Nephrotic Syndrome Trial in Cologne (Biosampling)
Recruiting
- Glomerulosclerosis, Focal Segmental
- +2 more
- Biosampling
-
Cologne, NRW, GermanyUniversity Hospital of Cologne
Nov 12, 2021
Adult and Child Patients and Parents of Swelling Due to
Recruiting
- Fluid Overload
- +12 more
- Interview
-
Ann Arbor, MichiganUniversity of Michigan
Aug 16, 2022
Nephrotic Syndrome in Children, Minimal Change Disease, Focal Segmental Glomerulosclerosis Trial in New Hyde Park, Philadelphia
Recruiting
- Nephrotic Syndrome in Children
- +2 more
- Transcutaneous auricular vagus nerve stimulation
- Sham device
-
New Hyde Park, New York
- +1 more
Dec 23, 2022
Alport Syndrome, Focal Segmental Glomerulosclerosis Trial in United States (R3R01)
Recruiting
- Alport Syndrome
- Focal Segmental Glomerulosclerosis
-
Los Angeles, California
- +10 more
Aug 15, 2022
Nephrotic Syndrome in Children, Minimal Change Disease, Focal Segmental Glomerulosclerosis Trial in New Hyde Park, Philadelphia
Recruiting
- Nephrotic Syndrome in Children
- +2 more
- trascutaneous auricular vagus nerve stimulation
- Sham device
-
New Hyde Park, New York
- +1 more
Dec 19, 2022
Focal Segmental Glomerulosclerosis Trial in United States (LIPOSORBER® LA-15 System)
Recruiting
- Focal Segmental Glomerulosclerosis
- LIPOSORBER® LA-15 System
-
Loma Linda, California
- +11 more
Mar 28, 2022
Kidney Disease, Chronic Trial in Australia, Spain, United States (BI 764198, Placebo)
Recruiting
- Kidney Disease, Chronic
- BI 764198
- Placebo
-
S. Gate, California
- +15 more
Aug 8, 2022
Primary Focal Segmental Glomerulosclerosis Trial in Rochester (Obinutuzumab)
Recruiting
- Primary Focal Segmental Glomerulosclerosis
-
Rochester, MinnesotaMayo Clinic in Rochester
Dec 13, 2021
Focal Segmental Glomerulosclerosis Trial in United States (Rituximab, Plasmapheresis)
Recruiting
- Focal Segmental Glomerulosclerosis
- Rituximab
- Plasmapheresis
-
Tuscaloosa, Alabama
- +13 more
Nov 16, 2021
NEPTUNE Match Study
Enrolling by invitation
- Nephrotic Syndrome in Children
- +7 more
- Communication
-
Atlanta, Georgia
- +15 more
Jan 30, 2023
Focal Segmental Glomerulosclerosis Trial in Dominican Republic, United States (Voclosporin)
Terminated
- Focal Segmental Glomerulosclerosis
-
Denver, Colorado
- +22 more
Aug 20, 2021
Rituximab for Refractory or Relapsed Focal Segmental
Completed
- Focal Segmental Glomerulosclerosis
- Minimal Change Disease
-
Istanbul, TurkeyIstanbul University
Nov 28, 2020
Understand Genetics and Clinical Course of Focal Segmental
Terminated
- Glomerulosclerosis, Focal Segmental
- +2 more
- FSGS/TR-MCD
- Diabetic Nephropathy (DN)
-
Mesa, Arizona
- +17 more
Jul 17, 2021